Clozapine N-oxide (CNO)
Tocris Bioscience | Catalog # 4936
Key Product Details
Description
Alternative Names
Product Description
Clozapine N-oxide is a synthetic ligand for human muscarinic engineered receptors, designer receptors activated by designer drugs (DREADD). Binds and activates hM3Dq and hM4Di DREADDs in vitro and in vivo. Metabolite of Clozapine (Cat. No. 0444). Shown to be a P-glycoprotein (P-gp) efflux pump substrate.
Example Applications of Clozapine N-oxide (CNO):
- Silences hippocampal neurons expressing hM4Di DREADDs in vitro
- Inhibits locomotor activity of mice expressing hM3Dq in GABAergic VTA neurons
- Inhibits short term memory retrieval in mice expressing hM4Di in hippocampal neurons
- Induces heat and mechanical hypersensitivity in mice expressing hM4Di in enkephalinergic neurons in the right lumbar dorsal horn
- Inhibits markers of social aggression in mice expressing hM4Di in hippocampal CA2 neurons
Alternative potent and selective hM3Dq and hM4Di DREADD agonists available: Deschloroclozapine and DREADD agonist 21
Water soluble salt also available.
This product contains 1 molar equivalent of ethanol.
Product Specifications for Clozapine N-oxide (CNO)
Molecular Weight
Formula
Storage
Purity
Chemical Name
CAS Number
PubChem ID
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 6.86 | 20 |
Preparing Stock Solutions for Clozapine N-oxide (CNO)
The following data is based on the product molecular weight 342.82.
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.2 mM | 14.58 mL | 72.92 mL | 145.85 mL |
| 1 mM | 2.92 mL | 14.58 mL | 29.17 mL |
| 2 mM | 1.46 mL | 7.29 mL | 14.58 mL |
| 10 mM | 0.29 mL | 1.46 mL | 2.92 mL |
Calculators
Background References
References are publications that support the biological activity of the product. See our Citations tab to view 514 publications citing the usage of this product.
- Roth DREADDs for Neuroscientists. Neuron 2016 PMID: 26889809
- Nakajima Gs-coupled GPCR signalling in AgRP neurons triggers sustained increase in food intake. Nat.Commun. 2016 PMID: 26743492
- Gomez Chemogenetics revealed: DREADD occupancy and activation via converted cloz. Science 2017 PMID: 28774929
- Zaman LMO4 is essential for paraventricular hypothalamic neuronal activity and calcium channel expression to prevent hyperphagia. J.Neurosci. 2014 PMID: 24381275
- Armbruster Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Proc.Natl.Acad.Sci.U.S.A. 2007 PMID: 17360345
- Eiermann The involvement of CYP1A2 and CYP3A4 in the metabolism of cloz. Br.J.Clin.Pharmacol. 1997 PMID: 9384460
Product Documents for Clozapine N-oxide (CNO)
Product Specific Notices for Clozapine N-oxide (CNO)
For research use only
Citations for Clozapine N-oxide (CNO)
Customer Reviews for Clozapine N-oxide (CNO) (8)
Have you used Clozapine N-oxide (CNO)?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Customer Images
-
Species: MouseAssay Type: In VivoCell Line/Tissue: neuronVerified Customer | Posted 06/15/20201 mg/kg
-
Species: MouseAssay Type: Ex VivoVerified Customer | Posted 01/04/2018Soluble in 0.9% saline. Perfused in brain slice experiment with patch clamp study.
-
Verified Customer | Posted 12/15/2017Product provides publishable work, no issues arose when dealing with the substance.CNO was used in pair with DREADD mice for a pain related experiment to determine whether inhibiting PBN neurons will attenuate pain reponses. Publication under second revision for Cell.
-
Verified Customer | Posted 12/01/2017I injected clozapine N-oxide in rats (IP, 1 mg/ml/kg). The rats had previously underwent stereotaxic surgery in which a virus carrying a gene for a Gi DREADD was infused unilaterally into the dorsal striatum.
-
Assay Type: In VivoVerified Customer | Posted 12/01/2017Added saccharine to counteract bitter taste of DMSO used to dissolve CNOIn vivo chemogenetic experiments - CNO was added to the drinking water. While there are issues with the back conversion of CNO to clozapine, this is not the manufacturer's problem. CNO experiments still generate important data as long as they utilize proper controls
-
Assay Type: In VivoVerified Customer | Posted 10/20/2017We use it as both injectable pass the blood brain barrier ICV, and IP injections. We are looking at both behavioral concern and brain regional efficacy in regard to DREADD. So far, this product has been selectively turning on/off our target cells.
-
Assay Type: Ex VivoVerified Customer | Posted 09/07/2017bleed assay
-
Assay Type: In VivoVerified Customer | Posted 07/17/2017neuron silencer
There are no reviews that match your criteria.